Tech Company Financing Transactions
Kano Therapeutics Funding Round
Kano Therapeutics closed a $5 million Seed financing round on 8/12/2024. Investors included The Engine, Vsquared Ventures and Metaplanet.
Transaction Overview
Company Name
Announced On
8/12/2024
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to develop its good laboratory practice (GLP) standards, design a process for clinical-grade production of kilobase ssDNA, and advance its internal and external programs through collaborative drug development.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
700 Main Street
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
Kano Therapeutics is a biotech company for targeted correction of gene-length stretches of DNA through a new class of biomaterial: circular single-stranded DNA. We develop safe, effective genetic payloads to cross the chasm to genetic cures.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Floris Engelhardt
VP - Bus. Development
John Vroom
VP - R & D
Alline Pacheco
Browse more venture capital transactions:
Prev: 8/12/2024: GoWit venture capital transaction
Next: 8/12/2024: Farmako venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs